Home NDC 0074-1044 EMRELIS
Product NDC 0074-1044
11-digit product format 000741044
Labeler code 0074
Product ID 0074-1044_998985bb-7cd1-4e80-bd08-8fc7c503f982
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Telisotuzumab Vedotin
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler AbbVie Inc.
Application BLA761384
Marketing category BLA
Marketing start 2025-05-14
Substance TELISOTUZUMAB VEDOTIN
Active strength 20 mg/mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base EMRELIS
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TELISOTUZUMAB VEDOTIN 20 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 976X9VXC3Z Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2714245 Internal RxNorm lookup 2714251 Internal RxNorm lookup 2714253 Internal RxNorm lookup 2714255 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0074-1044-01 EMRELIS 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 3 0074-1044-01 EMRELIS 1 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 1 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0074-1044 TELISOTUZUMAB VEDOTIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBVIE INC.] 2 Current NDC, 2 package rows 20250516_bc04f980-3957-4e35-ab81-8ec2ffe87215.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761384 Emrelis telisotuzumab vedotin-tllv 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 0074-1044-01 00074104401 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1044-01) / 1 mL in 1 VIAL, SINGLE-DOSE 2025-05-14 No No Current